Hjem › Interstitielle lungesykdommer › Utah
Kliniske studier for Interstitielle lungesykdommer i Utah
9 studier for Interstitielle lungesykdommer søker deltakere på steder i Utah.
Byer i Utah
Offisiell studietekst (engelsk)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Utah Health Sciences Center, Salt Lake City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07540988Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA025, Salt Lake City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07179380A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Salt Lake City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06572384A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Utah, Salt Lake City
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Utah, Salt Lake City
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Intermountain Medical Center, Murray
- University of Utah Health, Salt Lake City
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06388421Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Utah, Salt Lake City
RekruttererObservasjonsstudie
Alder 21 og eldre · Alle kjønn · Oppdatert 12. aug. 2026 · NCT01915511Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Intermountain Medical Center, Murray
- University of Utah Health, Salt Lake City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT05943535Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Salt Lake City
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. mai 2025 · NCT05892614Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.